REVERSE-TRANSKRIPTASE MIT VERBESSERTEN EIGENSCHAFTEN

Patent europeic · EP3058065 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3058065
Numer da la dumonda
EP14790465
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
16-10-2014
Publitgà
24-08-2016
Concedì
02-05-2018
Stritgà
31-10-2018
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 9/12 (2006.01)
C12N 15/10 (2006.01)
Prioritad
US 201361891554 P 16.10.2013
Dumonda PCT
PCT/US2014/060876 16.10.2014
Publicaziun PCT
WO2015/057950 23.04.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-05-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.05.2019

  2. 02-05-2018

    Concedì

    Published in Swissreg on 02.05.2018

Partidas

Possessur

New England BioLabs, Inc.

New England Biolabs, Inc.

240 County Road, Ipswich, MA 01938, US

Inventur

ZHANG, Yinhua

North Reading, MA 01864, US

EVANS, Thomas, C., Jr.

Topsfield, MA 01983, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.